BioDelivery Sciences (BDSI) Settles Patent Litigation with Teva (TEVA)

October 12, 2017 7:01 AM EDT Send to a Friend
BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login